SlideShare a Scribd company logo
1 of 32
By- Prashant Tiwari
M.Pharma. (Pharmaceutics)
Columbia Institute of
Pharmacy, Raipur, C.G.
Introduction
 The Food and Drug Administration (FDA or USFDA)

is an agency of the United States Department of
Health and Human Services
 It is responsible for regulating and supervising the

safety of foods, dietary supplements, drugs, vaccines,
biological medical products, blood products, medical
devices, radiation-emitting devices, veterinary
products, and cosmetics
Cont….
 The FDA has its headquarters at White Oak, Maryland.

The agency also has 223 field offices and 13 laboratories
located throughout the 50 states, the United States Virgin
Islands and Puerto Rico.
 In 2008, the FDA started opening offices in foreign

countries, including China , India , Costa Rica , Chile ,
Belgium and the United Kingdom.
FDA-Organisations
 The Office of the Commissioner (OC)

 The Center for Drug Evaluation and Research (CDER)
 The Center for Biologics Evaluation and Research (CBER)
 The Center for Food Safety and Applied Nutrition (CFSAN)
 The Center for Devices and Radiological Health (CDRH)
 The Center for Veterinary Medicine (CVM)
 The National Center for Toxicological Research (NCTR)
 The Office of Regulatory Affairs (ORA)
FDA-Legal Authoritys
 1902 – Biologics Control Act
 1906 – Pure Food and Drug Act
 1938 – Federal Food, Drug, and Cosmetic Act
 1944 – Public Health Service Act
 1951 – Food, Drug, and Cosmetics Act Amendments
 1962 – Food, Drug, and Cosmetics Act Amendments
 1966 – Fair Packaging and Labeling Act
 1976 – Medical Device Regulation Act
 1987 – Prescription Drug Marketing Act
Cont…..
 1988 – Anti–drug Abuse Act
 1990 – Nutrition Labeling and Education Act
 1992 – Prescription Drug User Fee Act
 1994 – Dietary Supplement Health and Education Act
 1997 – Food and Drug Modernization Act

 2002 – Bioterrorism Act
 2002 – Medical Device User Fee and Modernization Act

(MDUFMA)
 2003 – Animal Drug User Fee Act
 2007 – Food and Drug Administration Amendments Act
of 2007
FDA- Mission
Maintaining of FDA
 The FDA consists of employees drawn from a wealth of

science

and

public

health

professions.

Biologists,

physicians, chemists, biomedical engineers, toxicologists,
pharmacologists, veterinarians, and specialists in the
public health education and communication.

 FDA employs approximately 11,516 people who work in

locations around the United States.
FDA regulate?
 Foods, except for most meat and poultry products, which are











regulated by the U.S. Department of Agriculture.
Food additives
Infant formulas ,Dietary supplements
Human drugs
Vaccines, blood products, and other biologics
Medical devices, from simple items like tongue depressors, to
complex technologies such as heart pacemakers.
Electronic products that give off radiation, such as microwave
ovens and X-ray equipment.
Cosmetics.
Feed, drugs, and devices used in pets, farm animals, and other
animals.
Tobacco products
FDA shares the responsibility for regulating these
products with other government agencies:
 Pesticides (FDA, the U.S. Department of Agriculture, and

the Environmental Protection Agency regulate these).
 Water (FDA regulates the labeling and safety of bottled

water, while the Environmental Protection Agency
develops national standards for drinking water from
municipal water supplies).
Job of the FDA
 The FDA is the U.S. Government agency that oversees

most foods and medical products.
 Its job is to make sure that: Food is safe, healthy, and

clean. Medicines and medical devices are reasonably safe
and effective. Cosmetic products are safe. Animal foods
and drugs are safe. Food and medical products have
proper labels.
Regulatory programs
 The programs for safety regulation vary widely by the

type of product, its potential risks, and the regulatory
powers granted to the agency.
 The FDA regulates most products with a set of published

standards enforced by a modest number of facility
inspections.
 Inspection observations are documented on Form 483 .
FDA Inspection
FDA inspects manufacturers or processors of FDA-regulated
products to verify that they comply with relevant regulations.
Inspection include:






vaccine and drug manufacturers
blood banks
food processing facilities dairy farms animal feed processors
Facilities that conduct studies in people (clinical trials).
Laboratories that conduct studies in animals or microorganisms
when these studies are used to apply for FDA approval of a
medical product.
 Foreign manufacturing and processing sites for FDA- regulated
products that are sold in the United States. Imported products at
the border.
Cont…..
FDA conducts several types of inspections to help
protect consumers from unsafe products
 Pre-approval inspection after a company submits
an application to FDA to market a new product.
 Routine inspection of a regulated facility
 For-cause inspection to investigate a specific
problem that has come to FDA ’ s attention.
FDA makes available to the public certain
frequently requested records of inspections in an
electronic reading room .
Cont…..
Review of FDA inspectional guides
 Investigations Operations Manual (IOM)
 Compliance Program Guidance Manuals
(CPGM)
 Compliance Policy Guides(CPG)
Inspection Technical Guides Review of firm’s
Establishment Inspection Report (EIR)
Responses to FDA Form 483 etc.
Planning of inspections
Forms Commonly Used During
FDA Inspections
 FDA Form 482: Notice of inspection.

 FDA Form 483: Inspectional

observations.
 FDA Form 484: Receipt for physical
evidence (e.g., samples) , but not for
documentary evidence (e.g., label, copy
of records…).
Recall?
 A recall is when a product is removed from the

market or a correction is made to the product
because it is either defective or potentially
harmful.
 Sometimes a company discovers a problem and
recalls a product on its own.
 Other times a company recalls a product after
FDA raises concerns
CFR Title 21
 C.F. R – Code of federal Regulaion is a codification of

general rules and regulations also known as administrative
law published in the federal register by the executive
department and agencies of federal government of united
states
 Title 21 of the CFR is reserved for rules of the Food and
Drug Administration.
 CFR 21 was received from the Government Printing
Office (GPO) and contains the most recently received
revision.
 Food and Drugs: Parts 1 to 1499 different types of parts
to food, drug , cosmetic and medical devices and etc
Cont…..
 21 CFR part 11- Electronic submission and Electronic










signature
21 CFR part 50- Protection of human subjects
21 CFR part 54- Financial Disclosure by Clinical
Investigators
21 CFR part 56- Institutional Review Board
21 CFR part 101-Food Labelling.
21 CFR part 104-Nutritional quality guidelines for foods
21 CFR part 106- Infant Formula Quality Control
Procedures
21 CFR part 110- Cgmp Practices in manufacturing
packing or holding human food.
Cont…..
 21 CFR part 210- Cgmp Practices in

manufacturing, packing or holding of
Drugs:General
 21 CFR part 211- Cgmp Practices for finished
pharmaceuticals
 21 CFR part 225- Cgmp Practices for medicated
feeds.
 21 CFR part 312- Investigational new drug
application
 21 CFR part 314- Application for FDA Approval
to Market a New Drug
 21 CFR part 600 to 680- For biological products
FDA Guidelines to conduct cGMP
in Pharma Indutry
21 CFR part 210- Cgmp Practices in

manufacturing, packing or holding of
Drugs:General
21 CFR part 211- Cgmp Practices for
finished pharmaceuticals
21 CFR 210
210.1- Status of Cgmp regulation.
210.2-Applicability of Cgmp

regulation.
210.3- Definitions.
21 CFR 211
Subpart A- General provision:
211.1-scope

Subpart B- Organisation and
Personnel:
211.22-Responsibility of quality control unit.
211.25-Personnel qualification.
211.28-Personnel responsibility.
211.34-Consultants
21 CFR 211
Subpart C- Building and facilities:
211.42-Design and construction features.
211.44-Lighting
211.46-Ventilation,air filtration,air heating and cooling
211.48-Plumbing
211.50-Sewage and refuse.
211.52- Washing and toilet facilites
211.56-Sanitization
211.58-Maintenance
21 CFR 211
Subpart D- Equipment:
211.63- Equip. design,size and location.
211.65- Equip. constrution
211.67- Equip. cleaning and maintenance
211.68- Automatic,machanical and electonic Equip.
211.72- Filters.
21 CFR 211
Subpart E- Control of components ,
drug product container and closures:
211.80- General requirement
211.82- Receipt & storage of untested components
211.84-Testing of approval or rejection of components
211.86-Use of approved components
211.87- Retesting of approved components
211.89- Rejected components
211.94- Drug product container and closures
21 CFR 211
Subpart F-Prodution and process controls:
211.100- Written procedure and deviation
211.101- Charge in of components
211.103- Calculation of yield
211.105- Equip. identification
211.110- Sampling and testing of in-process drug
product
211.111- Time limitation on prodution
211.113-Control on microbiological contamination
211.115- Reprocessing
21 CFR 211
Subpart G-Packing and labelling control
211.122- Material examination and usage criteria
211.125-Labelling issuance
211.130-Packing and labelling operation
211.132-Tamper evident packing requi.for OTC Drug
product
211.134-Drug product inspection.
211.137-Expiration dating
21 CFR 211
Subpart H-Holding &Distribution:
211.142- Ware house procedure
211.150- Distribution procedure

Subpart I- Laboratory control:
211.160- General requirement
211.165-Testing and release for distribution
211.166-Stability testing
211.167- Special testing requirement
211.170- Reserve samples
211.173- Laboratory animals
21 CFR 211
Subpart J-Record and reports:
211.180- General requirement
211.182- Equip. cleaning and use log
211.184- Component, drug product container &
labelling records
211.186- Master prodution and control records
211.188- Batch prodution and control records
211.192- Prodution record review
211.194- Laboratory records
211.196- Distribution records
211.198- Complaint files.
21 CFR 211
Subpart K- Returned and salvaged drug
product:
211.204- Returned drug product
211.208- Drug product salvaging.

----------------------------------------------------
THANK YOU

More Related Content

What's hot

Good laboratory practices of pharmaceuticals
Good laboratory practices of pharmaceuticalsGood laboratory practices of pharmaceuticals
Good laboratory practices of pharmaceuticalssrilakshmisadam
 
Common Technical Document
Common Technical DocumentCommon Technical Document
Common Technical DocumentDr Sukanta sen
 
Regulatory authorities (US-FDA, WHO and ICH)
Regulatory authorities (US-FDA, WHO and ICH)Regulatory authorities (US-FDA, WHO and ICH)
Regulatory authorities (US-FDA, WHO and ICH)Sagar Savale
 
Out of specification shravan
Out of specification shravanOut of specification shravan
Out of specification shravanshravan dubey
 
Pharmaceutical validation & it's types
 Pharmaceutical validation & it's types Pharmaceutical validation & it's types
Pharmaceutical validation & it's typesAlexa Jacob
 
Regulatory affairs in Pharmaceutical Industry
Regulatory affairs in Pharmaceutical IndustryRegulatory affairs in Pharmaceutical Industry
Regulatory affairs in Pharmaceutical IndustryRama Shukla
 
USFDA guidelines of glp for non clinical testing laboratories
USFDA guidelines of glp for non clinical testing laboratoriesUSFDA guidelines of glp for non clinical testing laboratories
USFDA guidelines of glp for non clinical testing laboratoriesswrk
 
ICH: Introduction, objectives & guidelines: A brief insight.
ICH: Introduction, objectives & guidelines: A brief insight.ICH: Introduction, objectives & guidelines: A brief insight.
ICH: Introduction, objectives & guidelines: A brief insight.RxVichuZ
 
Indian GMP Certification & WHO GMP Certification
Indian GMP Certification & WHO GMP CertificationIndian GMP Certification & WHO GMP Certification
Indian GMP Certification & WHO GMP CertificationVishal Shelke
 
Current Good Manufacturing Practice (cGMP)
Current Good Manufacturing Practice (cGMP)Current Good Manufacturing Practice (cGMP)
Current Good Manufacturing Practice (cGMP)GOKULAKRISHNAN S
 
Investigational New drug application [INDA]
Investigational New drug application [INDA]Investigational New drug application [INDA]
Investigational New drug application [INDA]Sagar Savale
 

What's hot (20)

Good laboratory practices of pharmaceuticals
Good laboratory practices of pharmaceuticalsGood laboratory practices of pharmaceuticals
Good laboratory practices of pharmaceuticals
 
ICH GUIDELINES
ICH GUIDELINESICH GUIDELINES
ICH GUIDELINES
 
MHRA
MHRAMHRA
MHRA
 
Common Technical Document
Common Technical DocumentCommon Technical Document
Common Technical Document
 
Regulatory authorities (US-FDA, WHO and ICH)
Regulatory authorities (US-FDA, WHO and ICH)Regulatory authorities (US-FDA, WHO and ICH)
Regulatory authorities (US-FDA, WHO and ICH)
 
Usfda guidelines (1)
Usfda guidelines (1)Usfda guidelines (1)
Usfda guidelines (1)
 
Orange book
Orange bookOrange book
Orange book
 
Out of specification shravan
Out of specification shravanOut of specification shravan
Out of specification shravan
 
cGMP.
cGMP.cGMP.
cGMP.
 
Pharmaceutical validation & it's types
 Pharmaceutical validation & it's types Pharmaceutical validation & it's types
Pharmaceutical validation & it's types
 
What is FDA?
What is FDA?What is FDA?
What is FDA?
 
Regulatory affairs in Pharmaceutical Industry
Regulatory affairs in Pharmaceutical IndustryRegulatory affairs in Pharmaceutical Industry
Regulatory affairs in Pharmaceutical Industry
 
USFDA guidelines of glp for non clinical testing laboratories
USFDA guidelines of glp for non clinical testing laboratoriesUSFDA guidelines of glp for non clinical testing laboratories
USFDA guidelines of glp for non clinical testing laboratories
 
ICH: Introduction, objectives & guidelines: A brief insight.
ICH: Introduction, objectives & guidelines: A brief insight.ICH: Introduction, objectives & guidelines: A brief insight.
ICH: Introduction, objectives & guidelines: A brief insight.
 
WHO Guidance on Technology Transfers
WHO Guidance on Technology TransfersWHO Guidance on Technology Transfers
WHO Guidance on Technology Transfers
 
Regulatory affairs
Regulatory affairsRegulatory affairs
Regulatory affairs
 
Indian GMP Certification & WHO GMP Certification
Indian GMP Certification & WHO GMP CertificationIndian GMP Certification & WHO GMP Certification
Indian GMP Certification & WHO GMP Certification
 
DMF -Drug Master File
DMF -Drug Master File DMF -Drug Master File
DMF -Drug Master File
 
Current Good Manufacturing Practice (cGMP)
Current Good Manufacturing Practice (cGMP)Current Good Manufacturing Practice (cGMP)
Current Good Manufacturing Practice (cGMP)
 
Investigational New drug application [INDA]
Investigational New drug application [INDA]Investigational New drug application [INDA]
Investigational New drug application [INDA]
 

Similar to USFDA GUIDLINES

Fda gmp compliance for the Life Science Industry
Fda gmp compliance for the Life Science IndustryFda gmp compliance for the Life Science Industry
Fda gmp compliance for the Life Science Industrydmanalan
 
US - FDA Regulatory Agency Overview.
US - FDA Regulatory Agency Overview.US - FDA Regulatory Agency Overview.
US - FDA Regulatory Agency Overview.Venugopal N
 
Avoiding Pitfalls in the Regulatory Path - MaRS Best Practices
Avoiding Pitfalls in the Regulatory Path - MaRS Best PracticesAvoiding Pitfalls in the Regulatory Path - MaRS Best Practices
Avoiding Pitfalls in the Regulatory Path - MaRS Best PracticesMaRS Discovery District
 
Federal Regulatory Issues Us Food And Drug Administration Medical Device Amen...
Federal Regulatory Issues Us Food And Drug Administration Medical Device Amen...Federal Regulatory Issues Us Food And Drug Administration Medical Device Amen...
Federal Regulatory Issues Us Food And Drug Administration Medical Device Amen...Jacobe2008
 
5. Unit-V- Regulatory Concepts.
5. Unit-V- Regulatory Concepts.5. Unit-V- Regulatory Concepts.
5. Unit-V- Regulatory Concepts.Audumbar Mali
 
Pharmaceutical regulatory authorities and agencies
Pharmaceutical regulatory authorities and agenciesPharmaceutical regulatory authorities and agencies
Pharmaceutical regulatory authorities and agenciesChintamBaladattaSai
 
Ppt 1 overview of regulatory affairs and diff bodies_august2016_final
Ppt 1 overview of regulatory affairs and diff bodies_august2016_finalPpt 1 overview of regulatory affairs and diff bodies_august2016_final
Ppt 1 overview of regulatory affairs and diff bodies_august2016_finalRajashri Survase Ojha
 
Regulatory requirement for approval of Biologics
Regulatory requirement for approval of BiologicsRegulatory requirement for approval of Biologics
Regulatory requirement for approval of BiologicsArpitha Aarushi
 
Working in a_regulated_environment_presentation_ngan-winward
Working in a_regulated_environment_presentation_ngan-winwardWorking in a_regulated_environment_presentation_ngan-winward
Working in a_regulated_environment_presentation_ngan-winwardbio-link
 
CODE OF FEDERAL REGULATION CFR.pptx
CODE OF FEDERAL REGULATION CFR.pptxCODE OF FEDERAL REGULATION CFR.pptx
CODE OF FEDERAL REGULATION CFR.pptxGaneshSureshKumbhar
 
Regulatory authorities of copyright liasion
Regulatory authorities of copyright liasionRegulatory authorities of copyright liasion
Regulatory authorities of copyright liasionRAMZAHASHMI
 

Similar to USFDA GUIDLINES (20)

US FDA
US FDA US FDA
US FDA
 
Fda gmp compliance for the Life Science Industry
Fda gmp compliance for the Life Science IndustryFda gmp compliance for the Life Science Industry
Fda gmp compliance for the Life Science Industry
 
USFDA Over View
USFDA  Over ViewUSFDA  Over View
USFDA Over View
 
Usfda swatee
Usfda swateeUsfda swatee
Usfda swatee
 
Usfda
Usfda Usfda
Usfda
 
Usfda sana 1
Usfda sana 1Usfda sana 1
Usfda sana 1
 
Industry and fda laision &
Industry and fda laision &Industry and fda laision &
Industry and fda laision &
 
US - FDA Regulatory Agency Overview.
US - FDA Regulatory Agency Overview.US - FDA Regulatory Agency Overview.
US - FDA Regulatory Agency Overview.
 
Avoiding Pitfalls in the Regulatory Path - MaRS Best Practices
Avoiding Pitfalls in the Regulatory Path - MaRS Best PracticesAvoiding Pitfalls in the Regulatory Path - MaRS Best Practices
Avoiding Pitfalls in the Regulatory Path - MaRS Best Practices
 
Federal Regulatory Issues Us Food And Drug Administration Medical Device Amen...
Federal Regulatory Issues Us Food And Drug Administration Medical Device Amen...Federal Regulatory Issues Us Food And Drug Administration Medical Device Amen...
Federal Regulatory Issues Us Food And Drug Administration Medical Device Amen...
 
5. Unit-V- Regulatory Concepts.
5. Unit-V- Regulatory Concepts.5. Unit-V- Regulatory Concepts.
5. Unit-V- Regulatory Concepts.
 
Pharmaceutical regulatory authorities and agencies
Pharmaceutical regulatory authorities and agenciesPharmaceutical regulatory authorities and agencies
Pharmaceutical regulatory authorities and agencies
 
Ppt 1 overview of regulatory affairs and diff bodies_august2016_final
Ppt 1 overview of regulatory affairs and diff bodies_august2016_finalPpt 1 overview of regulatory affairs and diff bodies_august2016_final
Ppt 1 overview of regulatory affairs and diff bodies_august2016_final
 
Regulatory requirement for approval of Biologics
Regulatory requirement for approval of BiologicsRegulatory requirement for approval of Biologics
Regulatory requirement for approval of Biologics
 
Usfda ppn
Usfda ppnUsfda ppn
Usfda ppn
 
QMS and GMP
QMS and GMPQMS and GMP
QMS and GMP
 
Working in a_regulated_environment_presentation_ngan-winward
Working in a_regulated_environment_presentation_ngan-winwardWorking in a_regulated_environment_presentation_ngan-winward
Working in a_regulated_environment_presentation_ngan-winward
 
CODE OF FEDERAL REGULATION CFR.pptx
CODE OF FEDERAL REGULATION CFR.pptxCODE OF FEDERAL REGULATION CFR.pptx
CODE OF FEDERAL REGULATION CFR.pptx
 
Roshan (1)
Roshan (1)Roshan (1)
Roshan (1)
 
Regulatory authorities of copyright liasion
Regulatory authorities of copyright liasionRegulatory authorities of copyright liasion
Regulatory authorities of copyright liasion
 

Recently uploaded

ICT role in 21st century education and it's challenges.
ICT role in 21st century education and it's challenges.ICT role in 21st century education and it's challenges.
ICT role in 21st century education and it's challenges.MaryamAhmad92
 
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptxMaritesTamaniVerdade
 
Key note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfKey note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfAdmir Softic
 
Towards a code of practice for AI in AT.pptx
Towards a code of practice for AI in AT.pptxTowards a code of practice for AI in AT.pptx
Towards a code of practice for AI in AT.pptxJisc
 
The basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptxThe basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptxheathfieldcps1
 
How to Manage Global Discount in Odoo 17 POS
How to Manage Global Discount in Odoo 17 POSHow to Manage Global Discount in Odoo 17 POS
How to Manage Global Discount in Odoo 17 POSCeline George
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfagholdier
 
ICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxAreebaZafar22
 
Making communications land - Are they received and understood as intended? we...
Making communications land - Are they received and understood as intended? we...Making communications land - Are they received and understood as intended? we...
Making communications land - Are they received and understood as intended? we...Association for Project Management
 
Dyslexia AI Workshop for Slideshare.pptx
Dyslexia AI Workshop for Slideshare.pptxDyslexia AI Workshop for Slideshare.pptx
Dyslexia AI Workshop for Slideshare.pptxcallscotland1987
 
ComPTIA Overview | Comptia Security+ Book SY0-701
ComPTIA Overview | Comptia Security+ Book SY0-701ComPTIA Overview | Comptia Security+ Book SY0-701
ComPTIA Overview | Comptia Security+ Book SY0-701bronxfugly43
 
Understanding Accommodations and Modifications
Understanding  Accommodations and ModificationsUnderstanding  Accommodations and Modifications
Understanding Accommodations and ModificationsMJDuyan
 
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...christianmathematics
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdfQucHHunhnh
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxVishalSingh1417
 
Unit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxUnit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxVishalSingh1417
 
This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.christianmathematics
 
Introduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsIntroduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsTechSoup
 

Recently uploaded (20)

ICT role in 21st century education and it's challenges.
ICT role in 21st century education and it's challenges.ICT role in 21st century education and it's challenges.
ICT role in 21st century education and it's challenges.
 
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
 
Key note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfKey note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdf
 
Towards a code of practice for AI in AT.pptx
Towards a code of practice for AI in AT.pptxTowards a code of practice for AI in AT.pptx
Towards a code of practice for AI in AT.pptx
 
The basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptxThe basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptx
 
How to Manage Global Discount in Odoo 17 POS
How to Manage Global Discount in Odoo 17 POSHow to Manage Global Discount in Odoo 17 POS
How to Manage Global Discount in Odoo 17 POS
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdf
 
ICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptx
 
Making communications land - Are they received and understood as intended? we...
Making communications land - Are they received and understood as intended? we...Making communications land - Are they received and understood as intended? we...
Making communications land - Are they received and understood as intended? we...
 
Spatium Project Simulation student brief
Spatium Project Simulation student briefSpatium Project Simulation student brief
Spatium Project Simulation student brief
 
Dyslexia AI Workshop for Slideshare.pptx
Dyslexia AI Workshop for Slideshare.pptxDyslexia AI Workshop for Slideshare.pptx
Dyslexia AI Workshop for Slideshare.pptx
 
ComPTIA Overview | Comptia Security+ Book SY0-701
ComPTIA Overview | Comptia Security+ Book SY0-701ComPTIA Overview | Comptia Security+ Book SY0-701
ComPTIA Overview | Comptia Security+ Book SY0-701
 
Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024
 
Understanding Accommodations and Modifications
Understanding  Accommodations and ModificationsUnderstanding  Accommodations and Modifications
Understanding Accommodations and Modifications
 
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdf
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptx
 
Unit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxUnit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptx
 
This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.
 
Introduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsIntroduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The Basics
 

USFDA GUIDLINES

  • 1. By- Prashant Tiwari M.Pharma. (Pharmaceutics) Columbia Institute of Pharmacy, Raipur, C.G.
  • 2. Introduction  The Food and Drug Administration (FDA or USFDA) is an agency of the United States Department of Health and Human Services  It is responsible for regulating and supervising the safety of foods, dietary supplements, drugs, vaccines, biological medical products, blood products, medical devices, radiation-emitting devices, veterinary products, and cosmetics
  • 3. Cont….  The FDA has its headquarters at White Oak, Maryland. The agency also has 223 field offices and 13 laboratories located throughout the 50 states, the United States Virgin Islands and Puerto Rico.  In 2008, the FDA started opening offices in foreign countries, including China , India , Costa Rica , Chile , Belgium and the United Kingdom.
  • 4. FDA-Organisations  The Office of the Commissioner (OC)  The Center for Drug Evaluation and Research (CDER)  The Center for Biologics Evaluation and Research (CBER)  The Center for Food Safety and Applied Nutrition (CFSAN)  The Center for Devices and Radiological Health (CDRH)  The Center for Veterinary Medicine (CVM)  The National Center for Toxicological Research (NCTR)  The Office of Regulatory Affairs (ORA)
  • 5. FDA-Legal Authoritys  1902 – Biologics Control Act  1906 – Pure Food and Drug Act  1938 – Federal Food, Drug, and Cosmetic Act  1944 – Public Health Service Act  1951 – Food, Drug, and Cosmetics Act Amendments  1962 – Food, Drug, and Cosmetics Act Amendments  1966 – Fair Packaging and Labeling Act  1976 – Medical Device Regulation Act  1987 – Prescription Drug Marketing Act
  • 6. Cont…..  1988 – Anti–drug Abuse Act  1990 – Nutrition Labeling and Education Act  1992 – Prescription Drug User Fee Act  1994 – Dietary Supplement Health and Education Act  1997 – Food and Drug Modernization Act  2002 – Bioterrorism Act  2002 – Medical Device User Fee and Modernization Act (MDUFMA)  2003 – Animal Drug User Fee Act  2007 – Food and Drug Administration Amendments Act of 2007
  • 8. Maintaining of FDA  The FDA consists of employees drawn from a wealth of science and public health professions. Biologists, physicians, chemists, biomedical engineers, toxicologists, pharmacologists, veterinarians, and specialists in the public health education and communication.  FDA employs approximately 11,516 people who work in locations around the United States.
  • 9. FDA regulate?  Foods, except for most meat and poultry products, which are          regulated by the U.S. Department of Agriculture. Food additives Infant formulas ,Dietary supplements Human drugs Vaccines, blood products, and other biologics Medical devices, from simple items like tongue depressors, to complex technologies such as heart pacemakers. Electronic products that give off radiation, such as microwave ovens and X-ray equipment. Cosmetics. Feed, drugs, and devices used in pets, farm animals, and other animals. Tobacco products
  • 10. FDA shares the responsibility for regulating these products with other government agencies:  Pesticides (FDA, the U.S. Department of Agriculture, and the Environmental Protection Agency regulate these).  Water (FDA regulates the labeling and safety of bottled water, while the Environmental Protection Agency develops national standards for drinking water from municipal water supplies).
  • 11. Job of the FDA  The FDA is the U.S. Government agency that oversees most foods and medical products.  Its job is to make sure that: Food is safe, healthy, and clean. Medicines and medical devices are reasonably safe and effective. Cosmetic products are safe. Animal foods and drugs are safe. Food and medical products have proper labels.
  • 12. Regulatory programs  The programs for safety regulation vary widely by the type of product, its potential risks, and the regulatory powers granted to the agency.  The FDA regulates most products with a set of published standards enforced by a modest number of facility inspections.  Inspection observations are documented on Form 483 .
  • 13. FDA Inspection FDA inspects manufacturers or processors of FDA-regulated products to verify that they comply with relevant regulations. Inspection include:      vaccine and drug manufacturers blood banks food processing facilities dairy farms animal feed processors Facilities that conduct studies in people (clinical trials). Laboratories that conduct studies in animals or microorganisms when these studies are used to apply for FDA approval of a medical product.  Foreign manufacturing and processing sites for FDA- regulated products that are sold in the United States. Imported products at the border.
  • 14. Cont….. FDA conducts several types of inspections to help protect consumers from unsafe products  Pre-approval inspection after a company submits an application to FDA to market a new product.  Routine inspection of a regulated facility  For-cause inspection to investigate a specific problem that has come to FDA ’ s attention. FDA makes available to the public certain frequently requested records of inspections in an electronic reading room .
  • 15. Cont….. Review of FDA inspectional guides  Investigations Operations Manual (IOM)  Compliance Program Guidance Manuals (CPGM)  Compliance Policy Guides(CPG) Inspection Technical Guides Review of firm’s Establishment Inspection Report (EIR) Responses to FDA Form 483 etc. Planning of inspections
  • 16. Forms Commonly Used During FDA Inspections  FDA Form 482: Notice of inspection.  FDA Form 483: Inspectional observations.  FDA Form 484: Receipt for physical evidence (e.g., samples) , but not for documentary evidence (e.g., label, copy of records…).
  • 17. Recall?  A recall is when a product is removed from the market or a correction is made to the product because it is either defective or potentially harmful.  Sometimes a company discovers a problem and recalls a product on its own.  Other times a company recalls a product after FDA raises concerns
  • 18. CFR Title 21  C.F. R – Code of federal Regulaion is a codification of general rules and regulations also known as administrative law published in the federal register by the executive department and agencies of federal government of united states  Title 21 of the CFR is reserved for rules of the Food and Drug Administration.  CFR 21 was received from the Government Printing Office (GPO) and contains the most recently received revision.  Food and Drugs: Parts 1 to 1499 different types of parts to food, drug , cosmetic and medical devices and etc
  • 19. Cont…..  21 CFR part 11- Electronic submission and Electronic        signature 21 CFR part 50- Protection of human subjects 21 CFR part 54- Financial Disclosure by Clinical Investigators 21 CFR part 56- Institutional Review Board 21 CFR part 101-Food Labelling. 21 CFR part 104-Nutritional quality guidelines for foods 21 CFR part 106- Infant Formula Quality Control Procedures 21 CFR part 110- Cgmp Practices in manufacturing packing or holding human food.
  • 20. Cont…..  21 CFR part 210- Cgmp Practices in manufacturing, packing or holding of Drugs:General  21 CFR part 211- Cgmp Practices for finished pharmaceuticals  21 CFR part 225- Cgmp Practices for medicated feeds.  21 CFR part 312- Investigational new drug application  21 CFR part 314- Application for FDA Approval to Market a New Drug  21 CFR part 600 to 680- For biological products
  • 21. FDA Guidelines to conduct cGMP in Pharma Indutry 21 CFR part 210- Cgmp Practices in manufacturing, packing or holding of Drugs:General 21 CFR part 211- Cgmp Practices for finished pharmaceuticals
  • 22. 21 CFR 210 210.1- Status of Cgmp regulation. 210.2-Applicability of Cgmp regulation. 210.3- Definitions.
  • 23. 21 CFR 211 Subpart A- General provision: 211.1-scope Subpart B- Organisation and Personnel: 211.22-Responsibility of quality control unit. 211.25-Personnel qualification. 211.28-Personnel responsibility. 211.34-Consultants
  • 24. 21 CFR 211 Subpart C- Building and facilities: 211.42-Design and construction features. 211.44-Lighting 211.46-Ventilation,air filtration,air heating and cooling 211.48-Plumbing 211.50-Sewage and refuse. 211.52- Washing and toilet facilites 211.56-Sanitization 211.58-Maintenance
  • 25. 21 CFR 211 Subpart D- Equipment: 211.63- Equip. design,size and location. 211.65- Equip. constrution 211.67- Equip. cleaning and maintenance 211.68- Automatic,machanical and electonic Equip. 211.72- Filters.
  • 26. 21 CFR 211 Subpart E- Control of components , drug product container and closures: 211.80- General requirement 211.82- Receipt & storage of untested components 211.84-Testing of approval or rejection of components 211.86-Use of approved components 211.87- Retesting of approved components 211.89- Rejected components 211.94- Drug product container and closures
  • 27. 21 CFR 211 Subpart F-Prodution and process controls: 211.100- Written procedure and deviation 211.101- Charge in of components 211.103- Calculation of yield 211.105- Equip. identification 211.110- Sampling and testing of in-process drug product 211.111- Time limitation on prodution 211.113-Control on microbiological contamination 211.115- Reprocessing
  • 28. 21 CFR 211 Subpart G-Packing and labelling control 211.122- Material examination and usage criteria 211.125-Labelling issuance 211.130-Packing and labelling operation 211.132-Tamper evident packing requi.for OTC Drug product 211.134-Drug product inspection. 211.137-Expiration dating
  • 29. 21 CFR 211 Subpart H-Holding &Distribution: 211.142- Ware house procedure 211.150- Distribution procedure Subpart I- Laboratory control: 211.160- General requirement 211.165-Testing and release for distribution 211.166-Stability testing 211.167- Special testing requirement 211.170- Reserve samples 211.173- Laboratory animals
  • 30. 21 CFR 211 Subpart J-Record and reports: 211.180- General requirement 211.182- Equip. cleaning and use log 211.184- Component, drug product container & labelling records 211.186- Master prodution and control records 211.188- Batch prodution and control records 211.192- Prodution record review 211.194- Laboratory records 211.196- Distribution records 211.198- Complaint files.
  • 31. 21 CFR 211 Subpart K- Returned and salvaged drug product: 211.204- Returned drug product 211.208- Drug product salvaging. ----------------------------------------------------